Rheumatoid Arthritis – What Is New From SCR23?
During SCR23, Espen Haavardsholm, professor and president of the Scandinavian Society of Rheumatology, spoke about the current landscape with rheumatoid arthritis. In this Medtalk, he presents a few highlights from his SCR23 RA presentation, with a particular focus on the safety of JAK inhibitors and tapering medications for sustained remission.
Få tillgång
Om du är läkare, sjuksköterska eller annan vårdpersonal kan du komma åt hela artikeln genom att skapa en profil på BestPractice Nordic.
- Få tillgång
- Om du redan har en profil: Logga in
